Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Who is selling?

some parts of our post arn't to far away what many think of.

Sure, a recurring revenue stream is what we are missing. Dividens instead of collecting money to establish our own business are also a negative point. Being linked to TPL and being not able to act as a usual stock company is IMO the most worse point.

However, everybody claimed PTSC for the S/L warrants. They will be gone till autum. Share price and the markte didn't care much about it. MH was very positive. Share price and the market didn't care much about it. It's like a stand-of situation. Every good news is accompained by a negative one. So we stand where we are.

Nethertheless, the current PTSC is different and will be more different in the future when the puzzle is completed. Till this happens, patient is one of the most important thing.

GTLA

S402005

 

Share
New Message
Please login to post a reply